Philips’ Lumify Handheld Ultrasound System Adds Pulse Wave Doppler for Hemodynamic Assessment and Measurement

February 9, 2022—Royal Philips announced it has expanded its ultrasound portfolio with advanced hemodynamic assessment and measurement capabilities on the company’s Lumify handheld point-of-care ultrasound device. Philips’ Pulse Wave Doppler measurement is currently available on the Android Lumify app. Availability on the Apple iOS/iPad iOS Lumify app is scheduled for the future.

According to the company, the expanded utility of Lumify enables clinicians to quantify blood flow in a wide range of point-of-care diagnostic applications, including cardiology, vascular, abdominal, urology, obstetrics, and gynecology. Obstetric measurements are newly available to Lumify to help in early assessment of gestational age and identification of high-risk pregnancies.

Pulse Wave Doppler ultrasound provides clinicians with more information, in addition to two-dimensional and color imaging, to assess hemodynamic patterns to differentiate between arterial and venous blood flow and quantify hemodynamic function.

The company stated that Lumify now brings together imaging tools across ultrasound platforms and provides clinicians with advanced analysis software and reporting tools, as well as access to teleultrasound capabilities (via Lumify with Collaboration Live powered by Reacts) for live communication support to connect clinicians around the globe for real-time collaboration.

“Having Color Flow Doppler and Pulse Wave Doppler on a handheld device is game-changing, allowing clinicians to take point-of-care ultrasound examinations to the next level,” commented Robert Jones, DO, in the Philips press release. Dr. Jones, who is Professor of Emergency Medicine at MetroHealth System in Cleveland, Ohio, will discuss the clinical advantages and benefits of integrating Color Flow Doppler and Pulse Wave Doppler into the point-of-care ultrasound evaluation of acutely ill and injured patients in the emergency department in an upcoming webinar.

In addition to adding Pulse Wave Doppler for hemodynamics, Philips noted that its point-of-care ultrasound solution features the B-line quantification tool for ultrasound lung imaging. The B-lines software and intelligent algorithms enhance heart and lung assessments, particularly for severe COVID cases. Artificial intelligence–enhanced automated algorithms looking for B-lines in lung fluid can help provide more objective data and interpretation, stated the company.